Clinical Trial Update: A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas [Phase 1]

View source ↗

Summary

This report covers a Phase I trial of nanoliposomal irinotecan (NL-CPT-11) in patients with recurrent high-grade gliomas, completed to evaluate safety and preli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Nanoliposomal CPT-11 (NL-CPT-11) (irinotecan liposome)

Snippet

Sponsor: University of California, San Francisco | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: COMPLETED